Resource Center

The Importance of Training and Onboarding for Intranasal Rescue Therapies

Nasal drug repurposing has seen a real resurgence recently, driven by several factors. From an economic perspective, partners benefit from reduced development costs, intellectual property (IP) creation, increased market share… Read More »

Read More

Life Sciences Professional Jeffrey Miller Rejoins Noble International as Director, Business Development

FOR IMMEDIATE RELEASE CONTACT: Carolyn Reis, APR, at Carolyn@ReisCorporatePR.com or (407) 590-0251 ORLANDO, Fla. (February 10, 2020) — Noble International, an industry leader in developing training devices and onboarding solutions… Read More »

Read More

Enhancing the Patient Experience for Self-Injection Systems Through Demonstration Devices

Diagnoses of chronic illnesses such as rheumatoid arthritis (RA), Crohn’s disease and osteoporosis are expected to skyrocket in the coming decade, resulting in growing use of patient-centric drug delivery devices… Read More »

Read More

Response to News Release from 215 Biopharma KOLs

In the January 2020 edition of STAT News was a news release from 215 biopharma CEOs and industry leaders. The news release leverages 2020 as the beginning of “the dawn… Read More »

Read More

Aptar Pharma, Platinum Sponsor at DDL 2019, to Showcase Expanded Portfolio of Respiratory Innovations and Services

Aptar Pharma, a leading drug delivery systems provider, announces its Platinum Sponsorship of this year’s Drug Delivery to the Lung (DDL) Conference 2019, which takes place from December 11-13 in… Read More »

Read More

Aptar Acquires Noble International, a Leader in Drug Delivery Training Devices and Patient Onboarding

Crystal Lake, Illinois, October 31, 2019 – AptarGroup, Inc. (NYSE: ATR), a global leader in consumer dispensing, active packaging and drug delivery solutions, announced today that, subsequent to the end… Read More »

Read More